Skip to main content

Summary

for females ages 18–45 (full criteria)
at San Francisco, California and other locations
study started
estimated completion:

Description

Summary

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 4 years from birth.

Details

All pregnant women with IBD diagnosis who are taking biologics medicines and immunosuppressants will be entered in the study.

Keywords

Inflammatory Bowel Disease pregnant IBD patients Intestinal Diseases Inflammatory Bowel Diseases

Eligibility

You can join if…

Open to females ages 18–45

  • Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy

You CAN'T join if...

  • Pregnant female patients younger than 18 years of age
  • Confirmed multiple gestation

Locations

  • University of California San Francisco accepting new patients
    San Francisco, California, 94115, United States
  • Please Contact Natalia Wagner For Further Information Regarding Other Sites' Locations accepting new patients
    San Francisco, California, 94115, United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT00904878
Lead Scientist
Uma Mahadevan
Study Type
Observational
Last Updated
January 2016
I’m interested in this study!